Benzinga | Oct 11, 2021 06:56AM EDT

Berenberg Upgrades Eli Lilly to Buy, Raises Price Target to $270

Berenberg analyst Kerry Holford upgrades Eli Lilly (NYSE:LLY) from Hold to Buy and raises the price target from $240 to $270.